ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

CNTA Centessa Pharmaceuticals PLC

8.35
-0.40 (-4.57%)
May 23 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2021Dec 2021Mar 2022Dec 2022Mar 2023Jun 2023
USD ($)USD ($)
Total Revenue 00196k000
Operating Income -38.31M-58.29M-53.02M-41.6M-48.88M-47.02M
Pre Tax Income -40.16M-60.66M-54.42M-43.84M-50.04M-48.94M
Net Income -40.16M-60.77M-54.5M-43.17M-50.71M-24.89M
Preferred Dividends 000000
Basic Earnings Per Share (EPS) 000000
EBIT -40.22M-58.29M-53.02M-39.26M-50.22M-48.55M
EBITDA -38.31M-58.26M-53.02M-41.47M-48.79M-46.78M
Year End December 30 2022 20212022
USD ($)USD ($)
Total Revenue 00
Operating Income -374.08M-212.26M
Pre Tax Income -380.96M-216.95M
Net Income -381.07M-216.21M
Preferred Dividends 00
Basic Earnings Per Share (EPS) -4.235-2.28
EBIT -374.08M-209.92M
EBITDA -374.05M-212.13M

Your Recent History

Delayed Upgrade Clock